Moderna’s mFLUSIVA is the first mRNA flu vaccine approved in the US. It could make flu shots faster to update, but access remains unclear.
On August 5, 2025, the Department of Health and Human Services canceled 22 mRNA vaccine projects worth roughly $500 million and told the country it would stop investing in the technology that had bro… [+8465 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account